Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

RLFTF is now at the Level II stage of the ADR process. Sometime over the summer/fall they should reach Level III, and in/around that time RLFTF plans on uplisting to the NASDAQ. See their PRs on this which are posted on their web site. There is false information being circulated that RLFTF is in financial trouble. Per company guidance and their financial statements, they have enough cash to get through YEND 2023, and they have access to new funding if required. The ticker is in excellent standing with the OTCQB, and the ADR process to uplist to the NASDAQ is going according to plan.

Per the OTC Markets web site:
https://www.otcmarkets.com/stock/RLFTF/overview

OTCQB Member Since 08/2020
OTCQB
Verified Profile IconVerified Profile 01/2022

Dr Joey just recently released a new, very informative video (which someone else posted here today). Dr Joey drills down on RLFTF using fundamental analysis, and he projects out the future revenue streams from its various subsidiaries. RLFTF has a broad and deep pipeline, and the absence of Aviptadil to serve COVID-based ARDS has always been insignificant. In contrast, non-COVID ARDS applications for Aviptadil are more promising, and RAM has always been pursuing those avenues of revenue longer term.

The video does a fine job of breaking down key fundamental data related to projected future revenue streams (among other metrics). Here is the link again to his new video on fundamental analysis of RLFTF. You will need to first rewind it to the beginning because it was saved 1/3 into the 35 min video. It's a great video!